Clarivate earnings release, July 29, 2026

Clarivate Plc (CLVT) · Form 8-K, Item 2.02 · Filed · SEC filing

1

Clarivate Reports

Second

Quarter

2026

Results — Delivers continued progress on strategic and financial priorities through Value Creation Plan — — Sharpens focus and enhances financial profile with previously announced Life Sciences &

Healthcare segment divestiture — — Reaffirms 2026 financial outlook — London, UK --

July 29, 2026

Clarivate Plc (NYSE: CLVT) (the “Company” or “Clarivate”), a leading global provider of transformative intelligence, today reported results for the second quarter ended

June 30, 2026.

Executive Commentary

Matti Shem Tov, Chief Executive Officer:

“The Value Creation Plan continues to drive meaningful progress, as we execute against our strategic priorities and strengthen Clarivate’s foundation for organic growth acceleration. During the quarter, we expanded organic recurring revenue, advanced our AI innovation roadmap, maintained disciplined cost management, and strengthened our balance sheet through deleveraging. Together, with the recently announced divestiture of the

Life Sciences & Healthcare segment, these actions are creating a more focused company with greater financial flexibility, a higher recurring revenue mix, and a clear path to deliver long-term value to shareholders.”

Jonathan Collins, Executive Vice President and Chief Financial Officer:

“Our second quarter results reflect continued financial discipline and execution. In the first half of 2026, we expanded our profit margin and reduced debt by more than $200 million through strong free cash flow generation and opportunistic debt repurchases. Combined with our reaffirmed full-year outlook, these results demonstrate the resilience of our business model and our commitment to strengthening Clarivate’s financial profile while maintaining the flexibility to invest in our highest-value growth opportunities.”

Second

Quarter

2026

Results

Total revenues were

$587.3 million, compared to total revenues of

$621.4 million for the second quarter of

2025, primarily due to inorganic divestitures and disposals. Organic revenues decreased

1.5% as organic subscription growth of

0.7% was offset by lower organic transactional revenues.

Organic ACV grew

1.5% compared to

June 30, 2025, reflecting continued progress toward a more sustainable, subscription-led revenue base.

Net loss was

$268.6 million, or

$0.42 per diluted share, compared to a net loss of

$72.0 million, or

$0.11 per diluted share, for the second quarter of

2025, driven by a

$221.7 million non-cash goodwill impairment charge.

Adjusted net income was

$123.1 million, or

$0.19 per diluted share, compared to

$123.3 million, or

$0.18 per diluted share, for the second quarter of

2025. Adjusted EBITDA was

$247.2 million, compared to Adjusted

EBITDA of

$261.6 million for the second quarter of

2025.

First Half

2026

Results

Total revenues were

$1,172.8 million, compared to total revenues of

$1,215.1 million for the first six months of

2025, primarily due to inorganic divestitures and disposals. Organic revenues decreased

0.4%, as a

0.7% increase in organic recurring revenues (subscription and re-occurring) was offset by lower organic transactional revenues.

Net loss was

$308.8 million, or

$0.48 per diluted share, compared to a net loss of

$175.9 million, or

$0.26 per diluted share, for the first six months of

2025, driven by a

$221.7 million non-cash goodwill impairment charge in the second quarter of 2026. Adjusted net income was

$242.4 million, or

$0.38 per diluted share, compared to

$219.1 million, or

$0.32 per diluted share, for the first six months of

2025. Adjusted EBITDA was

$488.4 million, compared to Adjusted EBITDA of

$494.8 million for the first six months of

2025.

Clarivate generated

$233.4 million of operating cash flow and

$122.9 million of free cash flow during the first six months of

2026.²

Selected Financial Information

Second

Quarter

2026

Commentary

Subscription revenues decreased

$2.4 million, or

0.6%, to

$403.3 million, primarily due to product group wind- downs within LS&H. Organic subscription revenues increased

0.7%, primarily due to new sales and price increases.

Re-occurring revenues increased

$0.4 million, or

0.4%, to

$109.3 million, primarily due to foreign exchange benefit.

Recurring revenues, which consist of subscription and re-occurring revenues, increased

0.5% organically.

Transactional revenues decreased

$32.1 million, or

30.1%, to

$74.7 million, primarily due to product group wind- downs within A&G. Organic transactional revenues decreased

15.7%, primarily due to lower activity across all segments, driven in part by customer migrations to subscription offerings.

Balance Sheet and Cash Flow

As of

June 30, 2026, cash and cash equivalents of

$217.7 million decreased

$111.5 million compared to

December 31, 2025.

Total debt outstanding was

$4,251.5 million as of

June 30, 2026, a decrease of

$218.4 million compared to the prior year, driven by a $100.0 million accelerated debt repayment completed in January 2026, fully redeeming the senior secured notes due November 2026, as well as the retirement of

$117.6 million aggregate principal of the senior secured notes due 2028 and senior notes due 2029 through a series of debt repurchases at an approximate

6% discount to par.

Net cash provided by operating activities for the first six months of

2026 was

$233.4 million compared to

$287.5 million in the prior year period. Free cash flow for the first six months of

2026 was

$122.9 million compared to

$160.6 million in the prior year period.³

Reaffirms outlook for

2026

(forward-looking statement)

The full year outlook presented below assumes no further acquisitions, divestitures, or unanticipated events.

Notes to press release

(1)... (truncated)easures” in this release for important disclosures and reconciliations of these financial measures to the most directly comparable GAAP measure. These terms are defined elsewhere in this press release.

(2)

Adjusted diluted EPS for

2026 is calculated based on approximately

650 million fully diluted adjusted weighted average ordinary shares outstanding.

Conference Call and Webcast

Clarivate will host a conference call and webcast today to review the results for the second quarter at 9:30 a.m.

Eastern Time. The webcast is open to all interested parties and may include forward-looking information.

The live webcast of the earnings call will be accessible through the investor relations section of the Company’s website. To join the webcast please visit https://events.q4inc.com/attendee/248169870.

Interested parties may access the live audio broadcast. U.S. participants may call

833-461-5787; international participants may call +1

585-542-9983

(long-distance charges will apply). The conference ID number is

248169870.

A replay of the webcast will also be available on https://ir.clarivate.com beginning two hours after the conclusion of the live call and will remain available for one year.

Use of Non-GAAP Financial Measures

This release contains financial measures that have not been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”), including Adjusted EBITDA, Adjusted EBITDA margin, Adjusted net income,

Adjusted diluted EPS, Free cash flow, and Revenues, including discontinued operations. Non-GAAP financial measures are not recognized terms under GAAP, are not measures of financial condition or liquidity, and should not be considered as an alternative to profit or loss for the period determined in accordance with GAAP or operating cash flows determined in accordance with GAAP. As a result, you should not consider such measures in isolation from, or as a substitute for, financial measures or results of operations calculated or determined in accordance with GAAP.

We use non-GAAP measures internally in our operational and financial decision-making, to assess the operating performance of our business, to assess performance for employee compensation purposes, and to decide how to allocate resources. We believe that such measures allow us to focus on what we deem to be more reliable indicators of ongoing operating performance and our ability to generate cash flow from operations, and we also believe that investors may find these non-GAAP financial measures useful for the same reasons. Non-GAAP measures are frequently used by securities analysts, investors, and other interested parties in their evaluation of companies comparable to us, many of which present non-GAAP measures when reporting their results. Further, these measures can be useful in evaluating our performance against our peer companies because we believe they provide users with valuable insight into key components of our GAAP financial disclosure. However, non-GAAP measures have limitations as analytical tools and because not all companies use identical calculations, our presentation of non-GAAP financial measures may not be comparable to other similarly titled measures of other companies.⁴

Definitions and reconciliations of non-GAAP measures to the most directly comparable GAAP measures are provided within the schedules attached to this release. Our presentation of non-GAAP measures should not be construed as an inference that our future results will be unaffected by any of the adjusted items, or that any projections and estimates will be realized in their entirety or at all.

Financial statements

Income Statement

Three Months Ended June 30, — Selected Financial Information (In millions, except percentages and per share data)

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Change – $Change – %Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025Change – $Change – %
Revenues587.3621.4-34.1-5.5%1,172.81,215.1-42.3-3.5%
Net income (loss)-268.6-72-196.6N/M-308.8-175.9-132.9-75.6%
Adjusted net income(1)123.1123.3-0.2-0.2%242.4219.123.310.6%
Adjusted EBITDA(1)247.2261.6-14.4-5.5%488.4494.8-6.4-1.3%
Diluted EPS-0.42-0.11-0.31N/M-0.48-0.26-0.22-84.6%
Adjusted diluted EPS(1)0.190.180.015.6%0.380.320.0618.8%
Net cash provided by operating activities98.7116.3-17.6-15.1%233.4287.5-54.1-18.8%
Free cash flow(1)4450.3-6.3-12.5%122.9160.6-37.7-23.5%

Income Statement

The full year outlook presented below assumes no further acquisitions, divestitures, or unanticipated events.

Full Year 2026 Outlook
ACV Organic Growth2.0% to 3.0%
Recurring Organic Revenue Growth0.75% to 2.25%
Revenues, Including Discontinued Operations(1)$2.30B to $2.42B
Adjusted EBITDA(1)$980M to $1.04B
Adjusted EBITDA Margin(1)42.0% to 43.5%
Adjusted Diluted EPS(1)(2)$0.70 to $0.80
Free Cash Flow(1)$365M to $435M

Income Statement

Three Months Ended June 30, — Unaudited (In millions, except per share data)

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025
Revenues587.3621.41,172.81,215.1
Operating expenses:Cost of revenues185.5203.6377.6410.6
Operating expenses:Selling, general and administrative costs181.6181.1357.9359.5
Operating expenses:Depreciation and amortization185.7190.9369.7376.3
Operating expenses:Goodwill and intangible asset impairments221.7221.7
Operating expenses:Restructuring costs12.19.324.134
Operating expenses:Other operating expense (income), net0.929.6-8.248.6
Operating expenses:Total operating expenses787.5614.51,342.81,229
Operating expenses:Income (loss) from operations-200.26.9-170-13.9
Operating expenses:Interest expense, net60.466.6119.4130.9
Operating expenses:Income (loss) before income taxes-260.6-59.7-289.4-144.8
Operating expenses:Provision (benefit) for income taxes812.319.431.1
Operating expenses:Net income (loss)-268.6-72-308.8-175.9
Per share:Basic-0.42-0.11-0.48-0.26
Per share:Diluted-0.42-0.11-0.48-0.26
Weighted average shares used to compute earnings per share:Basic639.4681.3640685.5
Weighted average shares used to compute earnings per share:Diluted639.4681.3640685.5

Income Statement

Three Months Ended June 30, — and Net income (loss) margin for the same periods: (In millions, except percentages)

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025
Net income (loss)-268.6-72-308.8-175.9
Provision (benefit) for income taxes812.319.431.1
Depreciation and amortization185.7190.9369.7376.3
Interest expense, net60.466.6119.4130.9
Share-based compensation expense15.118.529.729.6
Goodwill and intangible asset impairments221.7221.7
Restructuring costs12.19.324.134
Transaction related costs10.28.118.414.4
Other(1)2.627.9-5.254.4
Adjusted EBITDA247.2261.6488.4494.8
Net income (loss) margin-45.7%-11.6%-26.3%-14.5%
Adjusted EBITDA margin42.1%42.1%41.6%40.7%

Income Statement

Three Months Ended June 30, — diluted EPS for the same periods: (In millions, except per share amounts)

Three Months Ended June 30, – 2026 – AmountThree Months Ended June 30, – 2026 – Per ShareThree Months Ended June 30, – 2025 – AmountThree Months Ended June 30, – 2025 – Per Share
Net income (loss) and Diluted EPS-268.6-0.42-72-0.11
Amortization related to acquired intangible assets135.30.211370.2
Share-based compensation expense15.10.0218.50.03
Goodwill and intangible asset impairments221.70.35
Restructuring costs12.10.029.30.01
Transaction related costs10.20.028.10.01
Other(1)4.3280.05
Income tax impact of related adjustments-7-0.01-5.6-0.01
Adjusted net income and Adjusted diluted EPS123.10.19123.30.18
Adjusted weighted average ordinary shares, diluted642.7684.6

Income Statement

Six Months Ended June 30, — operating performance. (In millions, except per share amounts)

Six Months Ended June 30, – 2026 – AmountSix Months Ended June 30, – 2026 – Per ShareSix Months Ended June 30, – 2025 – AmountSix Months Ended June 30, – 2025 – Per Share
Net income (loss) and Diluted EPS-308.8-0.48-175.9-0.26
Amortization related to acquired intangible assets270.70.42273.30.4
Share-based compensation expense29.70.0529.60.04
Goodwill and intangible asset impairments221.70.35
Restructuring costs24.10.04340.05
Transaction related costs18.40.0314.40.02
Other(1)-1.9-0.0154.50.09
Income tax impact of related adjustments-11.5-0.02-10.8-0.02
Adjusted net income and Adjusted diluted EPS242.40.38219.10.32
Adjusted weighted average ordinary shares, diluted645689.9

Income Statement

Year Ending December 31, 2026 (Forecasted) — per share for the same period:

Year Ending December 31, 2026 (Forecasted) – LowYear Ending December 31, 2026 (Forecasted) – High
Net income (loss) per share-0.64-0.54
Amortization related to acquired intangible assets0.830.83
Share-based compensation expense0.110.11
Goodwill and intangible asset impairments0.340.34
Restructuring costs(1)0.050.05
Transaction related costs0.050.05
Other-0.01-0.01
Income tax impact of related adjustments-0.03-0.03
Adjusted diluted EPS0.70.8
Adjusted weighted average ordinary shares, diluted~650 million

Balance Sheet

June 30, 2026 — Unaudited (in millions)

June 30, 2026December 31, 2025
Current assets:Cash and cash equivalents, including restricted cash217.7329.2
Current assets:Accounts receivable, net827.9821.7
Current assets:Prepaid expenses107.194.2
Current assets:Other current assets61.564.9
Current assets:Total current assets1,214.21,310
Current assets:Property and equipment, net49.552.7
Current assets:Other intangible assets, net7,734.38,008.1
Current assets:Goodwill1,344.91,566.7
Current assets:Other non-current assets86.568.1
Current assets:Deferred income taxes17.917.2
Current assets:Operating lease right-of-use assets38.846.6
Current assets:Total assets10,486.111,069.4
Current liabilities:Accounts payable152.9150.6
Current liabilities:Accrued compensation99146.7
Current liabilities:Accrued expenses and other current liabilities268.5273
Current liabilities:Current portion of deferred revenues897878.6
Current liabilities:Current portion of operating lease liability16.718.4
Current liabilities:Current portion of long-term debt1.6101.5
Current liabilities:Total current liabilities1,435.71,568.8
Current liabilities:Long-term debt4,209.34,321.5
Current liabilities:Other non-current liabilities75.886.2
Current liabilities:Deferred income taxes197.9212.1
Current liabilities:Operating lease liabilities29.937.9
Current liabilities:Total liabilities5,948.66,226.5
Shareholders' equity:Ordinary Shares, no par value; unlimited shares authorized; 639.7 and 640.7 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively12,815.212,810.6
Shareholders' equity:Accumulated other comprehensive loss-454.3-453.1
Shareholders' equity:Accumulated deficit-7,823.4-7,514.6
Shareholders' equity:Total shareholders' equity4,537.54,842.9
Shareholders' equity:Total liabilities and shareholders' equity10,486.111,069.4

Cash Flow

Six Months Ended June 30, — Unaudited (in millions)

Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025
Cash Flows From Operating ActivitiesNet income (loss)-308.8-175.9
Adjustments to reconcile net income (loss) to net cash provided by operating activities:Depreciation and amortization369.7376.3
Adjustments to reconcile net income (loss) to net cash provided by operating activities:Share-based compensation29.429.3
Adjustments to reconcile net income (loss) to net cash provided by operating activities:Goodwill and intangible asset impairments221.7
Adjustments to reconcile net income (loss) to net cash provided by operating activities:Deferred income taxes-11.3-5.4
Adjustments to reconcile net income (loss) to net cash provided by operating activities:Amortization and write-off of debt issuance costs6.67.7
Adjustments to reconcile net income (loss) to net cash provided by operating activities:Other operating activities-1448
Changes in operating assets and liabilities:Accounts receivable-11.32.2
Changes in operating assets and liabilities:Prepaid expenses-13.3-1.5
Changes in operating assets and liabilities:Other assets-53.1
Changes in operating assets and liabilities:Accounts payable3.2-3.3
Changes in operating assets and liabilities:Accrued expenses and other current liabilities-54.3-36.1
Changes in operating assets and liabilities:Deferred revenues24.442.6
Changes in operating assets and liabilities:Operating leases, net-1.9-3.2
Changes in operating assets and liabilities:Other liabilities-1.73.7
Changes in operating assets and liabilities:Net cash provided by operating activities233.4287.5
Cash Flows From Investing ActivitiesCapital expenditures-110.5-126.9
Cash Flows From Investing ActivitiesNet cash used for investing activities-110.5-126.9
Cash Flows From Financing ActivitiesPrincipal payments on debt-211.1-500
Cash Flows From Financing ActivitiesProceeds from issuance of debt500
Cash Flows From Financing ActivitiesPayment of debt issuance and extinguishment costs-8.5
Cash Flows From Financing ActivitiesRepurchases of ordinary shares-18.1-99.5
Cash Flows From Financing ActivitiesPayments related to tax withholding for share-based compensation-6.6-8.1
Cash Flows From Financing ActivitiesOther financing activities4.65.6
Cash Flows From Financing ActivitiesNet cash used for financing activities-231.2-110.5

Cash Flow

Three Months Ended June 30, — reconciles this non-GAAP measure to Net cash provided by operating activities for the same periods: (in millions)

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025
Net cash provided by operating activities98.7116.3233.4287.5
Capital expenditures-54.7-66-110.5-126.9
Free cash flow4450.3122.9160.6

Cash Flow

Year Ending December 31, 2026 (Forecasted) — measure to our Net cash provided by operating activities for the same period: (in millions)

Year Ending December 31, 2026 (Forecasted) – LowYear Ending December 31, 2026 (Forecasted) – High
Net cash provided by operating activities610680
Capital expenditures-245-245
Free cash flow365435
Full release

Forward-Looking Statements

This release includes statements that express our opinions, expectations, beliefs, plans, objectives, assumptions, or projections regarding future events or future results and therefore are, or may be deemed to be, “forward-looking statements” within the meaning of the “safe harbor provisions” of the Private Securities Litigation Reform Act of

1995. These forward-looking statements include all matters that are not historical facts, including statements relating to our intentions, beliefs, or current expectations concerning, among other things, the divestiture of our

Life Sciences & Healthcare business or any other strategic transactions we may explore, the anticipated use of proceeds from the divestiture of our Life Sciences & Healthcare business, anticipated cost savings or other benefits, results of operations, financial condition, liquidity, capital allocation plans and share repurchases, foreign exchange impacts, prospects, growth and shareholder value, strategies, and the markets in which we operate, our financial guidance for the fiscal year 2026 and key drivers thereof and underlying assumptions, the impact or anticipated benefits of our Value Creation Plan and other growth strategies, the global macroeconomic uncertainty and volatility, the impact of artificial intelligence (“AI”) on our business and strategy, and the timing of any of the foregoing. These forward-looking statements can generally be identified by the use of forward-looking terminology, including the terms “believes,” “estimates,” “anticipates,” “expects,” “seeks,” “projects,” “intends,”

“plans,” “may,” “will,” or “should” or, in each case, their negative or other variations or comparable terminology.

Such forward-looking statements are based on available current market material and management’s expectations, beliefs, and forecasts concerning future events impacting us. These forward-looking statements involve a number of risks and uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described in Item 1A. Risk... (truncated)m 10-K, along with our other filings with the U.S. Securities and Exchange

Commission (“SEC”). There can be no assurance that future developments affecting us will be those that we have anticipated. Should one or more of these risks or uncertainties materialize, or should any of the assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements.

We do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities laws. Please consult our public filings with the SEC, which are also available on our website at www.clarivate.com.

About Clarivate

Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property, and Life

Sciences & Healthcare. For more information, please visit www.clarivate.com.⁵

Condensed Consolidated Balance Sheets – Unaudited⁶

Condensed Consolidated Statements of Operations – Unaudited⁷

Condensed Consolidated Statements of Cash Flows – Unaudited⁸

Supplemental Revenues Information

Annualized contract value (“ACV”), at any point in time, represents the annualized value of all active customer subscription-based license agreements for the next 12 months, assuming those coming up for renewal during the measurement period are renewed at their current price level. Our organic ACV grew

1.5% compared to

June 30,

2025, primarily driven by improved product pricing. Our total ACV for

June 30, 2026, compared to

June 30,

2025, increased

3.1%, primarily due to improved product pricing and FX movements.

The following tables present our revenues by type and segment, as well as the components driving the changes between periods.

Revenues by transaction type

Revenues by segment⁹

Reconciliations to Certain Non-GAAP Measures

Adjusted EBITDA and Adjusted EBITDA margin

Adjusted EBITDA represents

Net income (loss) before the

Provision (benefit) for income taxes,

Depreciation and amortization, and

Interest expense, net, adjusted to exclude share-based compensation, impairments, restructuring expenses, the impact of certain non-cash fair value adjustments on financial instruments, acquisition and/or disposal-related transaction costs, unrealized foreign currency gains/losses, legal settlements, and other items that are included in

Net income (loss) for the period that we do not consider indicative of our ongoing operating performance. Net income (loss) margin is calculated by dividing

Net income (loss) by Revenues. Adjusted

EBITDA margin is calculated by dividing Adjusted EBITDA by Revenues.

The following table presents our calculation of

Adjusted EBITDA and

Adjusted EBITDA margin for the three and six months ended June 30, 2026 and

2025 and reconciles these non-GAAP measures to our

Net income (loss) and Net income (loss) margin for the same periods:

(1)

Includes the net impact of foreign exchange gains and losses related to the remeasurement of balances and other items that do not reflect our ongoing operating performance.

Adjusted net income and Adjusted diluted EPS

Adjusted net income represents Net income (loss), adjusted to exclude amortization related to acquired intangible assets, share-based compensation, impairments, restructuring expenses, the impact of certain non-cash fair value adjustments on financial instruments, acquisition and/or disposal-related transaction costs, unrealized foreign currency gains/losses, legal settlements, and other items that are included in net income (loss) for the period that we do not consider indicative of our ongoing operating performance and the associated income tax impact of such adjustments.

Adjusted diluted EPS is calculated by dividing Adjusted net income by Adjusted diluted weighted average shares.

The Adjusted diluted weighted average shares calculation assumes that all instruments in the calculation are dilutive.¹⁰

The following tables present our calculation of Adjusted net income and Adjusted diluted EPS for the three and six months ended June 30, 2026 and

2025 and reconciles these non-GAAP measures to our Net income (loss) and diluted EPS for the same periods:

(1)

Includes the net impact of foreign exchange gains and losses related to the remeasurement of balances and other items that do not reflect our ongoing operating performance.

(1)

Includes the net impact of foreign exchange gains and losses related to the remeasurement of balances and other items that do not reflect our ongoing operating performance.

Free cash flow

Free cash flow represents Net cash provided by operating activities less Capital expenditures. The following table presents our calculation of Free cash flow for the three and six months ended June 30, 2026 and

2025 and reconciles this non-GAAP measure to Net cash provided by operating activities for the same periods:¹¹

Reconciliations to Certain Non-GAAP Measures - 2026 Outlook

Adjusted EBITDA and Adjusted EBITDA margin

The following table presents our calculation of Adjusted EBITDA and Adjusted EBITDA margin for the 2026 outlook and reconciles these non-GAAP measures to our Net income (loss) and Net income (loss) margin for the same period:

(1)

Reflects restructuring costs expected to be incurred in 2026 associated with the Value Creation Plan.

Adjusted diluted EPS

The following table presents our calculation of Adjusted diluted EPS for the 2026 outlook and reconciles this non-

GAAP measure to our

Net income (loss) per share for the same period:

(1)

Reflects restructuring costs expected to be incurred in 2026 associated with the Value Creation Plan.¹²

Free cash flow

The following table presents our calculation of

Free cash flow for the

2026... (truncated)nciles this non-GAAP measure to our Net cash provided by operating activities for the same period:

Revenues, including discontinued operations

Revenues, including discontinued operations represents total company revenues including those attributable to discontinued operations, which will begin to be reported in the third quarter for the LS&H segment.

The following table presents our calculation of Revenues, including discontinued operations and reconciles this non-GAAP measure to our Revenues, excluding discontinued operations for the same period:

Media Contact:

Amy Bourke-Waite, Senior Director, Communications & Brand newsroom@clarivate.com

Investor Relations Contact:

Mark Donohue, Vice President, Investor Relations investor.relations@clarivate.com

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Clarivate earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.